Sign in

Neehar Parikh

@neeharparikh.bsky.social
689 followers 391 following 2 posts

Clinical Director of Hepatology at University of Michigan

PostsRepliesMedia
Reposted by Neehar Parikh
The New York Times @nytimes.com · 06/08/2026
Sydney Towle, who challenged assumptions about how people with serious illnesses should look and live on social media to more than a million followers, died on Wednesday at 26. nyti.ms/3UfO69U
56811
Reposted by Neehar Parikh
AASLD @aasldnews.bsky.social · 17/05/2026
Co-Editors-in-Chief Elliot B. Tapper, MD, FAASLD, and Carmen Chak-Lui Wong, PhD, share highlights from the May issue of #HepatologyCommunications. Watch below and view the latest issue here: journals.lww.com/hepcomm/pages/curr… www.youtube.com/watch?v=AS7wfJLg0c0
youtube.com
Hepatology Communications Highlights: May 2026
YouTube video by AASLDVideo
001
Reposted by Neehar Parikh
Detroit Free Press @freep.com · 07/04/2026
THE MICHIGAN WOLVERINES ARE NATIONAL CHAMPIONS! 〽️ U-M held off the blue-blood UConn Huskies on Monday night to win the NCAA Division I men's basketball championship, the second in school history. The win caps a 37-3 season that will go down as one of the greatest in college hoops history.
24218
Reposted by Neehar Parikh
The Athletic @theathletic.com · 07/04/2026
HAIL TO THE VICTORS 🔵🟡 THE MICHIGAN WOLVERINES HAVE WON THEIR FIRST MEN'S BASKETBALL NATIONAL CHAMPIONSHIP SINCE 1989!
733474
Reposted by Neehar Parikh
AASLD @aasldnews.bsky.social · 19/03/2026
🔥HOT TOPIC in #HepatologyCommunications Blood-based biomarker screening represents a transformative advance in liver cancer surveillance. Read the full study here: bit.ly/4bBmDFX
002
Reposted by Neehar Parikh
Dimitri Drekonja, MD, MS @dimitridrekonja.bsky.social · 24/01/2026
Alex from our time working together, while he was in nursing school. Later, he moved to ICU, working as a nurse to support critically ill Veterans. He had such a great attitude. We’d chat between patients about trying to get in a mountain bike ride together. Will never happen now
Alex Pretti from his early days working at the VA
626234997711
Reposted by Neehar Parikh
Dimitri Drekonja, MD, MS @dimitridrekonja.bsky.social · 24/01/2026
Alex Pretti was a colleague at the VA. We hired him to recruit for our trial. He became an ICU nurse- I lover working with him. He was a good kind person who lived to help and these fuckers executed him. White. Hot. Rage.
13856007218638
Reposted by Neehar Parikh
Mark Yarchoan @markyarchoan.bsky.social · 08/12/2025
We lost someone extraordinary: Ethan Neumann, a PhD candidate in my lab, worked tirelessly to study fibrolamellar carcinoma - the cancer that would ultimately claim his life Just before his died, he officially earned his doctorate and became Dr. Neumann → myarchoan.wixsite.com/yarchoanlabs...
142
Reposted by Neehar Parikh
AASLD @aasldnews.bsky.social · 08/11/2025
Celebrating excellence in hepatology! 🌟 We proudly recognized this year’s awardees and honorees at the #TLM25 Awards & Honors Gala. Join us in congratulating this incredible group of 2025 AASLD Distinguished Awardees! 👏👏
031
Reposted by Neehar Parikh
Atoosa Rabiee @atoosarabiee.bsky.social · 27/10/2025
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update If you take care of patients with #HCC, do not miss this new update from BCLC #liversky @easlnews.bsky.social www.journal-of-hepatology.eu/article/S016....
043
Reposted by Neehar Parikh
Eric Topol @erictopol.bsky.social · 21/10/2025
What did the largest trial of an early detection of cancer blood test show? erictopol.substack.com/p/the-larges...
erictopol.substack.com
The Largest Study of a Multi-Cancer Early Detection Blood Test
Reviewing the new data and the "liquid biopsy" field
310437
Reposted by Neehar Parikh
Lorenza Rimassa @lorenzarimassa.bsky.social · 19/10/2025
Richard Finn presents the results of phase 3 IMbrave152/SkYSCRAPER-14 study at #ESMO25 Anti-TIGIT tiragolumab does not add benefit to atezolizumab-bevacizumab for patients with advanced #HCC #ESMOAmbassadors @myesmo.bsky.social
053
Reposted by Neehar Parikh
Lorenza Rimassa @lorenzarimassa.bsky.social · 19/10/2025
CARES-009 phase 3 study of perioperative camrelizumab and rivoceranib for #HCC #ESMO25 #ESMOAmbassadors @myesmo.bsky.social
032
Reposted by Neehar Parikh
AASLD @aasldnews.bsky.social · 08/10/2025
Congratulations to AASLD’s newly elected 2026 SIG Steering Committee Leadership! Your enthusiasm, participation, and commitment to shaping AASLD were seen throughout the election process. Learn more: www.aasld.org/2026-aasld-special-in…
012
Reposted by Neehar Parikh
Peter Baker @peterbakernyt.bsky.social · 14/09/2025
Withdrawing from the War on Cancer: an extraordinarily successful scientific research system that took decades to build, saved millions of lives and generated billions of dollars in profits is being dismantled in short order. @jonathanmahler.bsky.social www.nytimes.com/2025/09/14/m...
nytimes.com
Trump Is Shutting Down the War On Cancer
44508273
Reposted by Neehar Parikh
George Conway ⚖️🇺🇸 @gtconway.bsky.social · 15/09/2025
631480573
Reposted by Neehar Parikh
AASLD @aasldnews.bsky.social · 12/09/2025
We are thrilled to announce the #AASLD 2025 Distinguished Award recipients! Join us in celebrating their achievements and commitment to #hepatology. Learn more about each recipient and their remarkable work: bit.ly/4giq0SS
101
Reposted by Neehar Parikh
Atoosa Rabiee @atoosarabiee.bsky.social · 08/09/2025
A very comprehensive review on current state of HCC screening, diagnosis and treatment. www.jhep-reports.eu/article/S258... #Liversky @easlnews.bsky.social
043
Reposted by Neehar Parikh
Heather Cherone @heathercherone.bsky.social · 02/09/2025
BREAKING: Gov. JB Pritzker says the Trump administration has sent the Texas National Guard to Great Lakes Naval Base outside Chicago, awaiting orders to deploy to Chicago. Trump administration officials will target Mexican Independence Day (Sept. 16) celebrations. @wttw.bsky.social
28846122175
Reposted by Neehar Parikh
Pierre Gholam MD @livermd.bsky.social · 16/08/2025
The @fda.gov just approved @novonordisk.bsky.social #wegovy on an accelerated path for #MASH F2/F3 fibrosis We now have 2 approved drugs with different MOA and that’s great news for patients. I anticipate at least 5 more approvals in the next 5 years. #liversky
131
Reposted by Neehar Parikh
The Baveno Cooperation: an EASL Consortium @bavenocoop.bsky.social · 16/07/2025
🖤 With deep sorrow, we announce the passing of Prof. Dr. Jaime Bosch, President of the Baveno Cooperation. A brilliant scientist, inspiring leader, and dear friend. His immense legacy in hepatology will endure. Rest in peace, Jaime
095
Reposted by Neehar Parikh
Chise @sailorrooscout.bsky.social · 16/05/2025
THIS IS HUGE! TWO Phase I HIV vaccine clinical trials have demonstrated that a stepwise mRNA-based vaccination strategy can SUCCESSFULLY activate AND advance immune responses toward producing broadly neutralizing antibodies (bnAbs), a CRITICAL milestone in HIV prevention. Let’s talk about that! 🧪🧵⬇️
3238991139
Reposted by Neehar Parikh
Eric Topol @erictopol.bsky.social · 06/04/2025
We've greatly underestimated the role of the gut microbiome in fatty liver disease (MASLD). This open-access outstanding review @jclinical-invest.bsky.social is illuminating www.jci.org/articles/vie...
1230255
Reposted by Neehar Parikh
Michigan Hepatology @michiganhepatology.bsky.social · 14/02/2025
📣UM Liver Cancer Diagnosis and Treatment CME Course on March 15th 2025 in Southfield, MI: in person and online. Featuring UM faculty and Dr. Laura Kulik from Northwestern University. Registration here: umich.cloud-cme.com/course/cours...
023
Reposted by Neehar Parikh
Arndt Vogel @arndtvogel.bsky.social · 04/03/2025
🔥Nivolumab and Ipilimuma approved by EMA for advanced hepatocellular carcinoma 🔥 👇https://ec.europa.eu/health/documents/community-register/html/h1014.htm 👉great news for our patients > more options in 1st line 😅amazing: approval in 🇪🇺by EMA before 🇺🇸by FDA @myESMO @EASLedu @ILCAnews #livertwitter
0136
Reposted by Neehar Parikh
Elliot Tapper @ebtapper.bsky.social · 01/03/2025
How do we interpret and act on disparities in liver cancer outcomes ?? Expert editorial by @laurennephewmd.bsky.social journals.lww.com/hepcomm/full... #liversky 1/
journals.lww.com
Learn, adapt, act: A pragmatic approach for intervening on... : Hepatology Communications
An abstract is unavailable.
154
Reposted by Neehar Parikh
The New York Times @nytimes.com · 27/02/2025
The sickest patients are supposed to get priority for lifesaving transplants. But nearly 20% of the time, the American organ transplant system is skipping over hundreds or even thousands of people when it distributes kidneys, livers, lungs and hearts, a New York Times investigation found.
nytimes.com
Organ Transplant System ‘in Chaos’ as Waiting Lists Are Ignored
The sickest patients are supposed to get priority for lifesaving transplants. But more and more, they are being skipped over.
1116852
Reposted by Neehar Parikh
Anjana Pillai @anjanapillaimd.bsky.social · 22/02/2025
Every year I feel so fortunate to be part of this #LiverCancer community with these amazing friends who are true leaders sharing a common goal!! Amongst the beautiful chaos that is life, it’s important to find your passion and your people 💚. That’s a wrap @hcclive.bsky.social
074
Neehar Parikh @neeharparikh.bsky.social · 21/02/2025
Very sad news regarding Josh Levitsky. He was a seminal mentor for me and a great friend. He will be missed. Much love to his family and the Northwestern Transplant family.
161
Reposted by Neehar Parikh
Rob Brierley @robbrierley.bsky.social · 21/02/2025
Routine [18F]FCH and [18F]FDG PET-CT for tumour staging in all patients with a 1st diagnosis of hepatocellular carcinoma has limited clinical value Guidelines should continue to emphasise morphological imaging (eg MRI & CT) for staging #OncSky #MedSky @oncoalert.bsky.social @naultjc.bsky.social
043
Reposted by Neehar Parikh
Elliot Tapper @ebtapper.bsky.social · 20/02/2025
This trial by @bloompringle.bsky.social will be seen as one of the most important in the field of FMT - 💩 transplant - for #cirrhosis Does the 💩 engraft? Does the 💩 work (improved barrier function)? This is why PPB is the future journals.lww.com/hepcomm/full... #liversky
journals.lww.com
Safety and efficacy of a defined bacterial consortium,... : Hepatology Communications
thods: We performed a single-center, randomized, placebo-controlled trial of VE303 in adult patients with a history of overt HE (NCT04899115). Eligible patients were taking lactulose and rifaximin, ...
0136
Reposted by Neehar Parikh
Resham Ramkissoon, MD @rayrammd.bsky.social · 11/02/2025
Great review of hemangiomas, FNH, & more by @renumathyd.bsky.social! I encourage all learners to read the classic imaging features. ✅️Review the imaging yourself ✅️Follow up if >5cm ✅️Biopsy for atypical appearance journals.lww.com/hepcomm/fullte… @jhepatology.bsky.social #Liversky #GITwitter
journals.lww.com
195
Reposted by Neehar Parikh
Josh Gerstein @joshgerstein.bsky.social · 10/02/2025
BREAKING: 22 states sue NIH over Trump administration's new 15% cap on overhead for federal research grants. Suit filed federal court in Boston contends lifesaving research 'will grind to a halt' under the policy. Doc: storage.courtlistener.com/recap/gov.us...
storage.courtlistener.com
6133391140
Reposted by Neehar Parikh
Elliot Tapper @ebtapper.bsky.social · 06/02/2025
BREAKING: rifaximin and simvastatin did not help people with decompensated cirrhosis Congratulations to Elisa Pose And congrats to @jama.com for getting this paper #liversky t.co/BuPL0mURhl
23510
Reposted by Neehar Parikh
Elliot Tapper @ebtapper.bsky.social · 30/01/2025
Can a pop up alert improve the quality of #cirrhosis care? Yes, #liversky Does improving adherence to quality measures improve outcomes? Not so fast New #medsky study: doi.org/10.14309/ajg... @amcollegegastro.bsky.social
doi.org
Electronic Interventions to Improve Quality for Inpatient... : Official journal of the American College of Gastroenterology | ACG
hemorrhage (AVH) or spontaneous bacterial peritonitis (SBP). Results: Our BPAs increased utilization. Ceftriaxone use was associated with adverse outcomes such as more blood product and broad-spect...
173
Reposted by Neehar Parikh
Elliot Tapper @ebtapper.bsky.social · 26/01/2025
How the environment impacts the liver And the risk of liver cancer Phenomenal review in Hep Comm: journals.lww.com/hepcomm/full... #liversky #medsky
0146
Reposted by Neehar Parikh
Nsikan Akpan @monscience.bsky.social · 22/01/2025
NIH appears to have canceled/postponed all of its study sections—the independent review panels that approve federal grants for health research. Such grants fund the work/salaries of 300k people at more than 2,500 institutions
30766503280
Reposted by Neehar Parikh
Anjana Pillai @anjanapillaimd.bsky.social · 22/01/2025
Hello #livertwitter friends- if you’re a liver cancer expert or want to be, please join us Feb 20-22 in Austin! We’d love to see you there! www.hcc-live.org @hcclive.bsky.social
hcc-live.org
023
Reposted by Neehar Parikh
Rob Brierley @robbrierley.bsky.social · 09/01/2025
New research - TACE combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study www.thelancet.com/journals/lan... @thelancet.bsky.social #MedSky #OncSky #LiverSky
0189
Reposted by Neehar Parikh
Atoosa Rabiee @atoosarabiee.bsky.social · 17/12/2024
Updated HCC management guidelines by @easlnews.bsky.social Must read 👇🏼👇🏼👇🏼 www.journal-of-hepatology.eu/article/S016... #Liversky
02715
Reposted by Neehar Parikh
Atoosa Rabiee @atoosarabiee.bsky.social · 10/12/2024
It's that time of the year again. In no particular order, I would like to share a few of #livertwitter in 2024 with #liversky These could be original research, guidance statement, position paper or editorial. This is def not an inclusive list. Feel free to add to the 🧵
12617
Reposted by Neehar Parikh
Katrina Ray @heykatray.bsky.social · 10/12/2024
NEW! #NatureReviewsGastroHep Review on current and emerging strategies for the prevention of hepatocellular carcinoma www.nature.com/articles/s41... 🔓 rdcu.be/d21qi #liversky #oncsky #livercancer #HCC
nature.com
Current and emerging strategies for the prevention of hepatocellular carcinoma - Nature Reviews Gastroenterology & Hepatology
Hepatocellular carcinoma (HCC) accounts for approximately 80% of all cases of primary liver cancer, the third leading cause of cancer mortality worldwide. In this Review, the authors discuss current a...
062
Reposted by Neehar Parikh
Michigan Hepatology @michiganhepatology.bsky.social · 05/12/2024
Congrats to our new GI and Hepatology Fellows!
042
Reposted by Neehar Parikh
Steven Bollipo @stevenbollipo.bsky.social · 18/11/2024
Thought provoking presentation from Renu on the topic of hepatologists and HCC management #TLM24 @atoosarabiee.bsky.social we need to get Renu here on blue sky!
083
Reposted by Neehar Parikh
Tony Breu @tonybreu.bsky.social · 11/11/2024
1/11 🤔Why does chronic hepatitis C infection "require" the intermediary of cirrhosis in order to cause hepatocellular carcinoma (HCC)? Chronic hepatitis B can "skip" this step, going directly from chronic infection to HCC. Why the difference?
86630